Adamis Pharmaceuticals Corporation ADMP
$ 0.78
0.86%
Quarterly report 2023-Q3
added 11-14-2023
Country |
USA |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Dennis Carlo |
Employees in the company |
131 |
Shares |
150 M |
Market Cap[1] |
$ 117 M |
EBITDA (LTM) |
$ -21.6 M |
P/E (LTM) |
-0.33 |
P/S (LTM) |
38.86 |
EPS (LTM) |
-2.37 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.